Reminder: jaguar health to hold investor webcast tuesday, august 13th at 8:30 am eastern to review q2 earnings and further review phase 3 ontarget trial's clinically meaningful results in breast and lung cancer patients

Jaguar to explore approval pathway for crofelemer in breast and lung cancer based on phase 3 results click here to register for investor webcast company plans to file its earnings report on august 13, 2024 on form 10-q for the quarter ended june 30, 2024 san francisco, ca / accesswire / august 12, 2024 / jaguar health, inc. (nasdaq:jagx) today issued a reminder that the company will conduct an investor webcast on tuesday, august 13, 2024 at 8:30 a.m. eastern to review second-quarter 2024 financials and provide corporate updates.
JAGX Ratings Summary
JAGX Quant Ranking